Physician-Scientist Reshma Kewalramani Runs One of Biotech's Biggest Companies [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Reshma Kewalramani Credit - Erin Clark—The Boston Globe/Getty Images A clear thread runs through Reshma Kewalramani's career, connecting her start as a kidney doctor, her years leading drug research and development at Amgen, and her present role as CEO and president of Vertex Pharmaceuticals . “What I wanted to do was make medicines for patients,” she says. Kewalramani took the helm of Vertex in 2020, a move that made her the first female CEO of a large, public biotechnology company. Under her leadership , Vertex in late 2023 launched the first CRISPR-based gene-editing therapy—a treatment for sickle-cell disease—and a new class of FDA-approved nonopioid pain medication in January 2025. The company has also continued to deliver breakthrough drugs for cystic fibrosis . “When I was in medical school, the average age of death [for patients with cystic fibrosis] was 27,” she says. Today, models suggest an average patient who starts medication in their youth will live beyond 70. But
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Crispr Therapeutics gains amid takeover speculation [Seeking Alpha]Seeking Alpha
- Is Vertex Stock Outperforming the Dow? [Yahoo! Finance]Yahoo! Finance
- TIME Reveals 2026 Women of the Year List Recognizing 16 Leaders Working Toward a More Equitable World [Yahoo! Finance]Yahoo! Finance
- Is Vertex Pharmaceuticals (VRTX) Now Offering A Compelling Entry Point After Flat One Year Returns [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) [Seeking Alpha]Seeking Alpha
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 2/27/26 - Form 144
- 2/27/26 - Form 144
- 2/26/26 - Form 4
- VRTX's page on the SEC website